BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25010664)

  • 21. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
    Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method.
    Ma S; Zhang Y; Huang J; Han X; Holford T; Lan Q; Rothman N; Boyle P; Zheng T
    Bioinformatics; 2010 Jan; 26(1):15-21. PubMed ID: 19850755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology studies on associations between gene polymorphisms and non-Hodgkin's lymphoma].
    Ye XB; Fu H
    Wei Sheng Yan Jiu; 2006 May; 35(3):384-6. PubMed ID: 16921776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.
    Dai ZM; He AL; Zhang WG; Liu J; Cao XM; Chen YX; Ma XR; Zhao WH; Dai ZJ
    Int J Clin Exp Med; 2014; 7(12):4720-33. PubMed ID: 25663969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking.
    Nandi S; Yu J; Burger AM; Reinert LS; Gartenhaus RB
    Leuk Lymphoma; 2006 Sep; 47(9):1806-12. PubMed ID: 17064992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development.
    Schuetz JM; Daley D; Leach S; Conde L; Berry BR; Gallagher RP; Connors JM; Gascoyne RD; Bracci PM; Skibola CF; Spinelli JJ; Brooks-Wilson AR
    PLoS One; 2013; 8(9):e75170. PubMed ID: 24098683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population.
    Lim YY; Chin YM; Tai MC; Fani S; Chang KM; Ong TC; Bee PC; Gan GG; Ng CC
    Leuk Lymphoma; 2015 Jan; 56(1):163-8. PubMed ID: 24684230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis.
    Alrashid MH; Al-Serri A; Alshemmari SH; Geo JA; Al-Bustan SA
    Cancer Biomark; 2021; 32(1):11-18. PubMed ID: 34024815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma.
    Worrillow L; Roman E; Adamson PJ; Kane E; Allan JM; Lightfoot TJ
    Cancer Epidemiol; 2009 Oct; 33(3-4):257-60. PubMed ID: 19736055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
    Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
    PLoS One; 2013; 8(9):e74619. PubMed ID: 24069324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
    Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
    Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
    PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
    Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.
    Lightfoot TJ; Skibola CF; Smith AG; Forrest MS; Adamson PJ; Morgan GJ; Bracci PM; Roman E; Smith MT; Holly EA
    Haematologica; 2006 Sep; 91(9):1222-7. PubMed ID: 16956821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
    Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis.
    Chen S; Zhu JH; Wang F; Huang SY; Xue WQ; Cui Z; He J; Jia WH
    Chin J Cancer; 2015 Mar; 34(3):108-14. PubMed ID: 25962431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.